Recent Posts

Showing posts with label Breast cancer patients. Show all posts
Showing posts with label Breast cancer patients. Show all posts

Wednesday, August 17, 2011

Medical Trial to treat Cancer Of The Breast Using CyberKnife Released

Breast cancer patient Kristin Wiginton is the first one to be treated at UT North western Clinic rich in-beam radiation while using Accuray CyberKnife System, that provides enhanced cosmetic results, less radiation contact with surrounding tissue along with a shorter treatment period.
Dr. Wiginton is one kind of 45 participants inside a UT North western-based medical trial -- the very first available within the Southwest -- looking into utilisation of the radiation delivery system for cancer of the breast. Her publish-lumpectomy therapy survived one-third the duration of the radiation session for any breast-cancer patient.
While CyberKnife has been utilized at UT North western since 1997, it mainly continues to be specific for growths from the brain and spine.
"If the hadn't exercised for me personally, I'd have gone with six . 5 days of traditional radiation," stated Dr. Wiginton, 45, an connect professor of health studies at Texas Woman's College.
Rather, her treatment required under two days and comprised of 5 90-minute periods every 2 to 3 days. Her final treatment was February. 3 at UT North western College Hospital -- Zale Lipshy.
Radiotherapy carrying out a lumpectomy is generally suggested to get rid of potential residual cancer, stated Dr. Robert Timmerman, professor of radiation oncology and nerve surgery who's leading the research. Current radiation methods for cancer of the breast, however, could be lengthy and uncomfortable. Shorter courses dealing with more compact breast volumes, known as partial breast irradiation, have proven considerable promise in studies, he stated. The most typical partial breast irradiation approach, brachytherapy, takes a catheter implant using a surgical treatment. Permanently provides the therapy using conventional radiotherapy equipment but can lead to less-pleasing cosmetic results.
Dr. Wiginton referred to her first CyberKnife session as painless. Though a little tired, she stated the therapy wasn't uncomfortable and she or he spent more often than not listing to music on her behalf ipod device.
"It's not necessary to be worried about moving an excessive amount of, since you they fit right into a mold," she stated, mentioning to some special padded mattress she rested on throughout the process.
The trial's protocol has been completed along with experts within the UT North western Center for Breast Care in the Harold C. Simmons Cancer Center, the only real National Cancer Institute-designated center in North Texas.
Patients planning for CyberKnife radiation remedies have minute gold seed markers known as fiducials inserted round the affected breast growth. The CyberKnife's image-led system tracks the fiducials to provide radiation towards the area, including moving with each breath taken through the patient.
Rather than standard radiotherapy systems that need heavy equipment with limited ability to move and beam direction, CyberKnife utilizes a lighter linear accelerator on the robot arm to concentrate multiple beams of radiation having a millimeter precision, while departing surrounding healthy tissue unscathed.
"The impetus with this protocol would be to avoid that invasiveness while still achieving excellent cosmetic results," stated Dr. Timmerman, mentioning towards the typical brachytherapy procedure. "This provides the equivalent radiation, however in a noninvasive way. Each [CyberKnife-shipped] beam is extremely weak, therefore it causes hardly any entry damage. It'll move about to 200 different positions."
Qualified participants should have localized early-stage cancer of the breast, should have effectively went through a lumpectomy and become a minimum of 18 years of age. Patients is going to be examined within the next ten years to see if they remain cancer-free, for potential cosmetic alterations in the breast and then any unexpected effects that could develop from radiation treatment.
Dr. Wiginton, known for that study by Dr. Serta Garwood, connect professor of radiation oncology, stated she hopes the process is going to be effective and provide new radiotherapy choices for breast cancer patients.
Because cardiovascular disease went her family, traditional radiotherapy wasn't the ideal choice for Dr. Wiginton because of potential harm to surrounding tissue, such as the heart. CyberKnife's precision greatly lessened that risk.
"If they are prepared to apply it to brain cancer, I believe it is a fairly safe wager to make use of inside a breast," Dr. Wiginton stated.


Saturday, August 13, 2011

Companions of Cancer Of The Breast Patients Are vulnerable to Developing Mood Disorders

A brand new analysis finds that males whose partners have cancer of the breast are in elevated chance of developing mood disorders which are so severe they warrant hospitalization. Released early online in Cancer, a peer-examined journal from the American Cancer Society, the research signifies that physicians should address the mental health of cancer patients' family members.
Illnesses can compromise the mental health of not just affected patients but of the nearest relatives too. Partners particularly are in risk simply because they may go through stressed and might be missing out on emotional, social, and economic support. A couple of small research has recommended that partners of cancer patients frequently develop major psychosocial problems however, data on partners' risk for severe depression is restricted.
Christoffer Johansen MD, PhD, DSc (Mediterranean), from the Institute of Cancer Epidemiology in Copenhagen, Denmark, brought a team that examined how often male partners of ladies with cancer of the breast are put in the hospital with affective disorders, including major depression, bipolar disease, along with other serious mood-changing conditions. The scientists examined data from 1,162,596 males who have been 3 decades or older, were living in Denmark, had no good reputation for hospitalization to have an affective disorder, coupled with resided continuously with similar partner not less than 5 years.
Throughout 13 many years of follow-up, cancer of the breast was identified within the partners of 20,538 males. A hundred 80 of those males were put in the hospital by having an affective disorder. Males whose partners were identified with cancer of the breast were 39 percent more prone to be being put in the hospital by having an affective disorder in comparison with males whose partners was lacking cancer of the breast. Additionally, males whose partners had severe cases of breast cancer were more prone to be put in the hospital than males whose partners had more gentle cases. Males whose partners experienced a relapse were also more prone to develop an affective disorder than individuals whose partners continued to be cancer-free. Males whose partners died after cancer of the breast were built with a 3.6-fold elevated chance of developing an affective disorder in comparison with males whose partners made it.
"An analysis of cancer of the breast not just affects the existence from the patient but could also seriously modify the partner," stated Prof. Johansen. "We recommend that some kind of screening from the partners of cancer patients generally as well as individuals of breast cancer patients particularly for depressive signs and symptoms may be essential for stopping this devastating results of cancer." Prof. Johansen also advocates for integrating partners within the clinical management of cancer.


Saturday, June 4, 2011

About 30% breast cancer patients in poor treatment

Breast cancer treatment to be divided into yin and yang principle, can not be generalized, HER2-positive breast cancer is difficult, the prognosis is not so optimistic. Breast cancer has become in Beijing, Shanghai, Guangzhou, Shenzhen and other cities in developed regions of China represented the most common cancer in women, which accounted for Jin Sancheng HER2-positive breast cancer. It and the general breast cancer compared to the more dangerous and poor prognosis.
HER2-positive breast cancer was Jinsan Cheng
Many people may not know, there are yin and yang of breast cancer law can not be unified treat! The past, we should always generally, early detection of breast cancer, early treatment, in fact, breast cancer is a group (family) disease, the human epidermal growth factor from receptor -2 (HER2) overexpression is divided into HER2 positive and HER2-negative breast cancer.
HER2-positive means "human epidermal growth factor receptor 2 overexpression." Means: "She" has been activated, the signal is passed to stimulate the proliferation of cancer cells crazy, so HER2-positive patients often precedes endocrine therapy is not sensitive to rapid tumor progression, prone to lymph node or hematogenous metastasis, poor prognosis. In breast cancer patients, who showed Jinsan Cheng HER2 positive breast cancer are "diehards", not only rapid tumor progression, treatment is also very difficult.
Did not do half of HER2 testing in breast cancer patients
Although the popularization of knowledge with the disease, public awareness of prevention and treatment of breast cancer also increased, but the national survey data, only 57% of breast cancer patients have HER2 testing. Distinguish yin and yang, it is easy to miss treatment opportunities. Subtypes to determine which specific treatment with, otherwise the treatment of excessive or unreasonable treatment, will give an adverse impact on survival of breast cancer patients. JISHOU said.
According to reports, HER2 detection methods There are three, namely, immunohistochemistry (IHC), show in situ hybridization (CISH) and fluorescence in situ hybridization (FISH). Typically, patients with IHC do first check, if the test results is 3 plus, he was diagnosed with HER2-positive; if the result is a plus or a 0, compared with HER2-negative; If the test results is 2 plus doctor will do it again CISH or FISH were checked for the final diagnosis. If CISH or FISH tests positive, he was diagnosed with HER2-positive, or negative.
Targeted therapy can reduce the risk of HER2-positive breast cancer death
Breast cancer is the control effect of the medical profession generally considered one of the better tumor. However, for the treatment of HER2 positive breast cancer more difficult, according to the traditional surgery, chemotherapy and endocrine therapy, there are still many patients with distant recurrence. This part of the patients, the need for early selection of targeted therapy. National Comprehensive Cancer Network (NCCN) guidelines recommend the Chinese version of CNCCN HER2-positive patients with trastuzumab with adjuvant chemotherapy program. This means that, while patients in the chemotherapy for targeted therapy. Currently, the global research and clinical application showed that this treatment can be targeted to HER2-positive early breast cancer recurrence rate has dropped 52%, 35% reduction in the risk of death; advanced HER2-positive breast cancer up to 61% remission rate .


Friday, June 3, 2011

Breast cancer patients: to correct errors, active treatment

Breast cancer is the occurrence of glandular tissue in breast cancer, 99% in women, male breast cancer accounts for about 1%. 30-year-old women in our country the incidence of breast cancer began to rise with increasing age, mostly in high-risk age 40 to 50 years old, 5-10 years after menopause also appear a small peak.
Ordinary women: self-prevention "Zimo" No
Breast cancer is terrible, causing many women appear once aware of breast lumps or soft or hard on the "extremely suspicious" at a loss. "How good, to suffer from breast hyperplasia? It is a tumor you?" Many "patients" made such a question. "Hyperplasia is a common benign, the possibility of cancer is very small, not nervous." Pangda professor explained, "women of normal menstrual cycles, changes in the environment, work pressure, eating habits and so may lead to female breast hyperplasia, but 90% of all benign breast hyperplasia, and does not cause cancer, but women friends also do not therefore ignore breast health. "
Life, many women believe that self-examination can prevent cancer, they would rather spend thousands of dollars to do beauty treatments cost less than a hundred dollars for breast examination but "you could save on the province", which is a misunderstanding must be corrected . Professor Pang Da, although the self-examination is very important, but many no clinical signs of early breast cancer can not be found through the self-test, the National Comprehensive Cancer Centre Alliance announced the 2005 cancer diagnosis and treatment guidelines Jiuyi this method is no longer recommended . A variety of reasons, many women do not have the life of a normal breast examination.
"The best in the mass-age women has not yet appeared before the implementation of prevention programs for breast cancer, do not passively wait for the doctor to check the advice given," Pangda professors recommend women under 35 years of age should receive an annual breast ultrasound examination because Women in this age group with high breast density, mammography X ray is difficult to penetrate, observation is unclear. Women over the age of 35 breast tissue began to shrink gradually replaced by fat tissue, mammography X-ray irradiation effect, the accuracy rate up to 80%.
High risk for breast cancer, such as age of menarche is less than 12 years of age or menopausal age older than 55 years of age, first child bearing age over 35 or childbirth, postpartum who are not breast-feeding, family history of breast cancer patients who, it is recommended Regular breast X-ray examination at the same time, combined with monthly self-examination and regular clinical examination, once found a lump, be sure to confirm the diagnosis as soon as possible.
When the need to identify when the tumor is benign or malignant, doctors often advise patients to biopsy, but many patients worry that this will be very painful puncture or cause risk of spread of tumor cells, so afraid to even refused biopsy. In this regard, Professor Pang Da explains: "needle biopsy is the most reliable means of diagnosis of breast cancer, currently no evidence that the biopsy will lead to the spread of tumor cells, which do not have too much worry and fear. In other countries, must Most breast cancer patients are also obtained by needle biopsy and diagnosed. "
Breast cancer: an active treatment to correct errors
According to the views of the World Health Organization, breast cancer is through early diagnosis and early treatment significantly reduced mortality of cancer. If early diagnosis and prompt treatment, the cure rate can be as high as 95%. However, due to the traditional "cancer is incurable," "Once the cancer was found to survive for very long," deep-rooted misconceptions, making many reluctant to diagnose breast cancer, or treatment after diagnosis has lost confidence. Also some of the young breast cancer patients refused surgery for beauty, which missed the best time for treatment, and some middle-aged women, although the length of a lump found in breast, but also a feeling that may be cancer, but taking into account the economic conditions and their children burden, would rather endure the pain does not go to hospital and treatment.
For these cases, Pangda professor said: "If you can make early diagnosis of breast cancer, early treatment can often get good treatment, but if because of delays caused by exacerbations, often the cost will be higher post-treatment, the treatment effect is poor, the burden on patients and their families will be even heavier. For beauty of women friends who now have a new surgical and orthopedic technology, women can restore the beauty and confidence. "
He appealed to the majority of female friends must not hide his body abnormalities, suffer in silence, if early diagnosis and timely surgery, is expected to be cured, and can return to society, and ordinary people, the life and work, is also very high survival rate of more than ten years , spent most provinces.


Twitter Delicious Facebook Digg Favorites More